Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

[This corrects the article DOI: 10.1371/journal.pntd.0005969.].

Bibliographic Details
Main Authors:	Robert A Harrison, George O Oluoch, Stuart Ainsworth, Jaffer Alsolaiss, Fiona Bolton, Ana-Silvia Arias, José-María Gutiérrez, Paul Rowley, Stephen Kalya, Hastings Ozwara, Nicholas R Casewell
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-08-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0008698

Similar Items

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
by: Robert A Harrison, et al.
Published: (2017-10-01)

An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
by: Stuart Ainsworth, et al.
Published: (2020-08-01)

Biogeographic venom variation in Russell's viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots.
by: R R Senji Laxme, et al.
Published: (2021-03-01)

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
by: Laura-Oana Albulescu, et al.
Published: (2020-12-01)

Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
by: Laura-Oana Albulescu, et al.
Published: (2021-06-01)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
by: Timothy Patrick Jenkins, et al.
Published: (2020-07-01)

An investigation of snakebite antivenom usage in Taiwan
by: Chih-Chuan Lin, et al.
Published: (2016-08-01)

Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
by: Abdulrazaq G Habib, et al.
Published: (2015-01-01)

Recent Advances in Next Generation Snakebite Antivenoms
by: Cecilie Knudsen, et al.
Published: (2018-04-01)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
by: Emilie Alirol, et al.
Published: (2015-09-01)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
by: José María Gutiérrez, et al.
Published: (2021-06-01)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims
by: R. Manjunatha Kini, et al.
Published: (2018-12-01)

In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms
by: Janeyuth Chaisakul, et al.
Published: (2020-12-01)

A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite
by: Laura-Oana Albulescu, et al.
Published: (2019-07-01)

History of Snakebite Envenomation Treatment and Contribution of Turkey to Global Antivenom Production
by: Can Sarica, et al.
Published: (2018-12-01)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.
by: Muhammad Hamza, et al.
Published: (2016-03-01)

Venomous snakebites and antivenom treatment according to a protocol for pediatric patients in taiwan
by: JD Wang, et al.
Published: (2009-01-01)

Bioinformatic design of venom toxin-specific antivenom to improve the treatment of snakebite in Africa
by: Rengifo Ibanez, Maria Camila
Published: (2013)

Antivenom Therapy for Crotaline Snakebites: Has the Poison Control Center Provided Effective Guidelines?
by: Yen-Chia Chen, et al.
Published: (2007-12-01)

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
by: Andreas H Laustsen, et al.
Published: (2017-02-01)

Third-generation antivenomics analysis of the preclinical efficacy of Bothrofav® antivenom towards Bothrops lanceolatus venom
by: Davinia Pla, et al.
Published: (2019-01-01)

Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy
by: Cecilie Knudsen, et al.
Published: (2020-08-01)

Evaluation of the geographical utility of Eastern Russell's viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity.
by: Janeyuth Chaisakul, et al.
Published: (2019-10-01)

A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (The QUALISnake Study).
by: Joseir Saturnino Cristino, et al.
Published: (2021-03-01)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sanjib Kumar Sharma, et al.
Published: (2019-01-01)

Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).
by: Christopher I Johnston, et al.
Published: (2012-01-01)

Incorporating the 3Rs (Refinement, Replacement and Reduction of animals in research) into the preclinical assessment of snake venom toxicity and antivenom efficacy
by: Bolton, F. M.
Published: (2017)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
by: Emilie Alirol, et al.
Published: (2017-05-01)

Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms
by: Juan J. Calvete, et al.
Published: (2014-12-01)

Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14).
by: George E Allen, et al.
Published: (2012-01-01)

Potential Utilization of a Polysaccharide from the Marine Algae <i>Gayralia oxysperma</i>, as an Antivenom for Viperidae Snakebites
by: Ana Cláudia Rodrigues da Silva, et al.
Published: (2018-10-01)

Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
by: Diana Mora-Obando, et al.
Published: (2021-02-01)

Using geographical information systems to identify populations in need of improved accessibility to antivenom treatment for snakebite envenoming in Costa Rica.
by: Erik Hansson, et al.
Published: (2013-01-01)

Successful snakebite treatment in three juvenile African wild dogs (Lycaon pictus) with polyvalent antivenom: A Namibian case report
by: Marlice van Vuuren, et al.
Published: (2013-03-01)

Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: An open randomized controlled phase IIb clinical trial.
by: Iran Mendonça-da-Silva, et al.
Published: (2017-11-01)

Successful snakebite treatment in three juvenile African wild dogs (<i>Lycaon pictus</i>) with polyvalent antivenom: A Namibian case report
by: Florian J. Weise, et al.
Published: (2013-03-01)

An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity.
by: Kamille E Krause, et al.
Published: (2020-06-01)

Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.
by: H Asita de Silva, et al.
Published: (2011-05-01)

Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae
by: Alejandro García-Arredondo, et al.
Published: (2019-03-01)

Beyond the 'big four': Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies.
by: R R Senji Laxme, et al.
Published: (2019-12-01)